-
Trastuzumab deruxtecan, sold
under the
brand name Enhertu, is an antibody-drug
conjugate consisting of the
humanized monoclonal antibody trastuzumab (Herceptin)...
-
Datopotamab deruxtecan, sold
under the
brand name Datroway, is an anti-cancer
medication used for the
treatment of
breast cancer. It is a Trop-2-directed...
-
Deruxtecan is a
chemical compound and a
derivative of
exatecan that acts as
topoisomerase I inhibitor. It is
available linked to
specific monoclonal antibody...
-
Datopotamab deruxtecan (Dato-DXd)
Patritumab deruxtecan (HER3-DXd) VN-0102 DS-1647
Ifinatamab deruxtecan (I-DXd; DS-7300)
Raludotatug deruxtecan (R-DXd; DS-6000)...
-
Ifinatamab deruxtecan (DS-7300) is an
experimental anti-cancer
treatment developed by
Merck and
Daiichi Sankyo. It is an antibody–drug
conjugate that "consists...
-
Patritumab deruxtecan (U3-1402/ MK-1022) is an
experimental antibody–drug
conjugate developed by
Merck and
Daiichi Sankyo to
treat non-small-cell lung...
-
camptothecin with
antineoplastic activity. A
derivative is used in
Trastuzumab deruxtecan. Abou-Alfa, GK; Letourneau, R; Harker, G; Modiano, M; Hurwitz, H; Tchekmedyian...
- L01FX33
Tarlatamab L01FX34
Odronextamab L01FX35
Datopotamab deruxtecan L01FX36
Patritumab deruxtecan L01FY01
Pertuzumab and
trastuzumab L01FY02
Nivolumab and...
-
chemotherapy today: topotecan, irinotecan, belotecan, and
trastuzumab deruxtecan.
Camptothecin has also been
found in
other plants including Chonemorpha...
-
diseases This
antigen is the
target of
sacituzumab govitecan and
datopotamab deruxtecan (Dato-DXd), both antibody-drug conjugates. GRCh38:
Ensembl release 89:...
